Advertisement
Screener

CapsoVision, Inc (CV) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

1.4 / 5 stars · 2/7 Roast Me

CapsoVision, Inc Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

CapsoVision, Inc (CV) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 2.81 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-13

  • CapsoVision, Inc antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 2.81M shares, a 93.11% decline year-over-year.
  • CapsoVision, Inc antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 2.20M shares, a 94.61% decline year-over-year.
  • CapsoVision, Inc antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 2.30M shares, a 94.07% decline year-over-year.
  • CapsoVision, Inc antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 40.82M shares, a 10.57% increase year-over-year.
  • CapsoVision, Inc antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 21.40M shares, a 47.77% decline from fiscal 2024.
  • CapsoVision, Inc antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 40.98M shares.
Period endAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month
2026-06-302.81M shares
10-Q · filed 2026-08-13
2.51M shares
10-Q · filed 2026-08-13
2026-03-312.20M shares
10-Q · filed 2026-05-14
2025-12-3121.40M shares
10-K · filed 2026-03-26
2025-09-302.30M shares
10-Q · filed 2025-11-13
27.64M shares
10-Q · filed 2025-11-13
2025-06-3040.82M shares
10-Q · filed 2026-08-13
40.83M shares
10-Q · filed 2026-08-13
2025-03-3140.86M shares
10-Q · filed 2026-05-14
2024-12-3140.98M shares
10-K · filed 2026-03-26
2024-09-3038.75M shares
10-Q · filed 2025-11-13
37.55M shares
10-Q · filed 2025-11-13
2024-06-3036.92M shares
10-Q · filed 2025-08-14
36.95M shares
10-Q · filed 2025-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Electromed, Inc. (ELMD)United States$0.233B31.13
EDAP TMS SA (FOCL)$0.171B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53
Vivani Medical, Inc. (VANI)United States$0.111B
electroCore, Inc. (ECOR)United States$0.102B
Neuraxis, INC (NRXS)United States$0.097B
Nexalin Technology, Inc. (NXL)United States$0.094B
Streamex Corp. (STEX)United States$0.089B-0.19
Outset Medical, Inc. (OM)United States$0.059B-1.09
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B